NEW YORK, Sept. 5, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. . Such investors are advised to contact Robert S. Willoughby.
NEW YORK, Aug. 28, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. . Such investors are advised to contact Robert S. Willoughby at.
Anticipated at a compound annual growth rate of approximately 4% from 2020 onwards, the market for cancer-supportive care products shows promising expansion. Erythropoietin-stimulating agents are positioned to capture the largest share of revenue, owing to their proven effectiveness in addressing anemia induced by c.
NEW YORK, Aug. 20, 2023 (GLOBE NEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX). Such investors are